Levels of Circulating MMCN-151, a Degradation Product of Mimecan, Reflect Pathological Extracellular Matrix Remodeling in Apolipoprotein E Knockout Mice
Aim Arterial extracellular matrix (ECM) remodeling by matrix metalloproteinases (MMPs) is one of the major hallmarks of atherosclerosis. Mimecan, also known as osteoglycin has been implicated in the integrity of the ECM. This study assessed the validity of an enzyme-linked immunosorbent assay (ELISA...
Main Authors: | N. Barascuk, E. Vassiliadis, Q. Zheng, Y. Wang, W. Wang, L. Larsen, L.M. Rasmussen, M.A. Karsdal |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-01-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.4137/BMI.S7777 |
Similar Items
-
Levels of Circulating MMCN-151, a Degradation Product of Mimecan, Reflect Pathological Extracellular Matrix Remodeling in Apolipoprotein E Knockout Mice
by: N. Barascuk, et al.
Published: (2011-09-01) -
Mimecan: A Newly Identified Adipokine and Regulator of Appetite
by: Amanda J. Page
Published: (2015-11-01) -
Data on the value of elevated circulating mimecan levels for detecting poor coronary collateralization in patients with stable angina and chronic total occlusion
by: Ying Shen, et al.
Published: (2016-12-01) -
Mimecan, a Hormone Abundantly Expressed in Adipose Tissue, Reduced Food Intake Independently of Leptin Signaling
by: Huang-Ming Cao, et al.
Published: (2015-11-01) -
Novel Cardiac-Specific Biomarkers and the Cardiovascular Continuum
by: Efstathios Vassiliadis,, et al.
Published: (2012-05-01)